RAMZORDiagnostic

Company Overview

Snapshot

Founded in October 2019 by Boris Melnik and Ilya Mezhibovsky, RAMZORDiagnostic operated with 1–10 employees. The company ceased operations in April 2022.

Business overview

RAMZORDiagnostic was developing a real-time noninvasive tissue examination system designed for early melanoma detection. The core technology utilized spectral signatures to map metabolic activity in the skin, providing an early warning system for skin tissue damage and disease progression. The company's algorithm, based on multi-year research, focused on understanding changes in the optical properties of skin correlated with melanoma growth. RAMZORDiagnostic aimed to serve the digital healthcare and medical diagnostics sectors, targeting hospitals, doctors, clinics, and insurance companies with its B2B and B2G business models.

Company Intelligence Q&A

What is RAMZORDiagnostic's primary focus?

RAMZORDiagnostic focused on developing a noninvasive early melanoma detection system that utilizes spectral signatures to map metabolic activity in the skin.

When was RAMZORDiagnostic founded?

RAMZORDiagnostic was founded in October 2019.

Who are the founders of RAMZORDiagnostic?

The company was founded by Boris Melnik, who served as Co-founder & CEO, and Ilya Mezhibovsky, who was Co-Founder & Business Development.

What was the operational status of RAMZORDiagnostic?

RAMZORDiagnostic ceased to operate in April 2022.

What markets did RAMZORDiagnostic target?

RAMZORDiagnostic targeted the digital healthcare and medical diagnostics sectors, with a focus on hospitals, doctors, clinics, and insurance companies in Israel.